ALBANO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 152
AS - Asia 86
EU - Europa 74
SA - Sud America 3
AF - Africa 2
Totale 317
Nazione #
US - Stati Uniti d'America 151
SG - Singapore 68
IT - Italia 36
CN - Cina 9
SE - Svezia 9
BG - Bulgaria 7
GB - Regno Unito 5
IE - Irlanda 4
IN - India 4
RU - Federazione Russa 3
AT - Austria 2
BE - Belgio 2
BR - Brasile 2
DE - Germania 2
AZ - Azerbaigian 1
EG - Egitto 1
FR - Francia 1
GR - Grecia 1
HK - Hong Kong 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
TG - Togo 1
Totale 317
Città #
Singapore 55
Santa Clara 40
Florence 13
Cambridge 10
Fairfield 9
Sofia 7
Chandler 5
Ashburn 4
Dublin 4
Houston 4
Milan 3
Wilmington 3
Woodbridge 3
Beijing 2
Bologna 2
Brussels 2
Collecchio 2
Lonato 2
London 2
Montemiletto 2
Moscow 2
New York 2
Pescia 2
Porto Alegre 2
Porto Torres 2
Princeton 2
Verdellino 2
Verona 2
Almaty 1
Andover 1
Athens 1
Baku 1
Bengaluru 1
Boardman 1
Buffalo 1
Cairo 1
Catania 1
Des Moines 1
Faisalabad 1
Falkenstein 1
Gangnam-gu 1
Kunming 1
Lima 1
Lomé 1
Millbury 1
Naples 1
Norwalk 1
Nuremberg 1
Plano 1
San Diego 1
Seattle 1
Totale 213
Nome #
null 55
Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial 38
Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996 31
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 25
Ten-Year Follow-up of Patients with Chronic Myeloid Leukemia Treated with Nilotinib in First-Line: Final Results of the Gimema CML 0307 Trial 22
Real Life Evaluation of Efficacy and Safety of Bosutinib Therapy in Chronic Myeloid Leukemia Patients 17
COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey 16
Low Cholesterol, Low-Density Lipoprotein (LDL) and Triglycerides Plasma Levels Are Associated with Lower Risk of Arterial Occlusive Events in Chronic Myeloid Leukemia Patients Treated with Nilotinib 15
Multicenter, Prospective and Retrospective Observational Cohort Study of Ponatinib in Patients with CML in Italy: Interim Analysis of the OITI Trial 15
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative 13
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 13
How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey 12
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. ACampus CMLstudy 11
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 11
Favorable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib 11
Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia 11
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors 11
Chronic Myeloid Leukemia Italian Multicenter Observational Study (CML-IT-MOS): Clinical Characteristics of Chronic Myeloid Leukemia (CML) Patients Treated in Real-Life between 2012 and 2016 in 66 Italian Hematology Centers of the Gimema Study Group 10
Arterial Occlusive Events in Chronic Myeloid Leukemia Patients Treated with Ponatinib in the Real-Life Practice: Prophylaxis and Identification of Risk Factors 7
Totale 344
Categoria #
all - tutte 1.951
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.951


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 4 2 2 1 2 1
2020/20213 0 1 0 0 0 0 0 0 1 0 1 0
2021/202222 0 0 0 1 4 0 0 2 2 2 9 2
2022/202327 4 2 2 1 5 3 1 2 6 0 0 1
2023/2024141 26 14 11 16 19 13 2 0 0 23 6 11
2024/2025116 4 40 4 10 40 18 0 0 0 0 0 0
Totale 344